The goal of the NHLBI Progenitor Cell Biology Consortium (PCBC) is to identify and characterize progenitor cell lineages, to direct the differentiation of stem and progenitor cells to desired cell fates, and to develop new strategies to address the unique challenges presented by the transplantation of these cells.
Stem Cell-Derived Blood Products for Therapeutic Use (R01)
Funding Opportunity Purpose
Attached is a set of slides and a publication that are a reference for applying for K awards presented by Dr. Lis Welniak, program officer from the NHLBI.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
NIH Guide Notices:
NHLBI Announces Frequently Asked Questions (FAQs) for RFA-HL-15-005 “Revision Applications for Research Using Aged Animal Models to Study Chronic Disorders of Heart, Lung, Blood, and Sleep (R01)”, NOT-HL-14-237, National Heart, Blood, and Lung Institute.
Request for Information (RFI): Consideration of Sex As a Biological Variable in Biomedical Research (NOT-OD-14-128) Office of the Director, NIH.
The PCBC is offering another specialized stem cell course on advance hESCs techniques and cardiovascular differentiation techniques at Stanford University in February 2015. Attached below are course materials from previous training sessions for your review. Please note that a bioinformatics component will be added to the first week of the course.
The PCBC is offering crowdsourcing as a method for U01 Hub Site investigators to solve discrete problems that have them stumped. Participation of bright and creative individuals in the PCBC provides considerable potential for crowdsourcing.
The PCBC Skills Development Committee would like to share some exciting training opportunities with you. Skills development training sessions are open to applications from any graduate student, post-doctoral fellow or faculty member working in a PCBC Hub Site laboratory.
In May 2014, the National Center for Advancing Translational Sciences (NCATS) issued the following four funding announcements: